Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report

Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report

Key Clinical Message Thrombotic microangiopathies are a side effect of anti‐VEGF therapies, which are often limited to the kidneys but can also occur systemically and be life‐threatening. Screening for increasing proteinuria is essential. Abstract We present the case of a 65‐year‐old male patient wi...

Full description

Bibliographic Details
Main Authors: Marco Stortz, Kateryna Shmanko, Daniel Kraus, Simon Gairing, Simone Boedecker‐Lips, Friederich Förster, Arndt Weinmann, Julia Weinmann‐Menke
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Clinical Case Reports
Subjects:
bevacizumab
HCC
plasma exchange
thrombotic microangiopathy
Online Access:https://doi.org/10.1002/ccr3.8124

Similar Items

Similar Items